Aloxiprin
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C18H15AlO9 |
Molar mass | 402.288 g/mol |
WikiDoc Resources for Aloxiprin |
Articles |
---|
Most recent articles on Aloxiprin |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Aloxiprin at Clinical Trials.gov Clinical Trials on Aloxiprin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Aloxiprin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Aloxiprin Discussion groups on Aloxiprin Directions to Hospitals Treating Aloxiprin Risk calculators and risk factors for Aloxiprin
|
Healthcare Provider Resources |
Causes & Risk Factors for Aloxiprin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Aloxiprin (or aluminium acetylsalicylate) is a medical drug used for the treatment of pain and inflammation associated with muscular skeletal and joint disorders.[1] It is used for its properties as an anti-inflammatory, antipyretic and analgesic drug.[1] It is a chemical compound of aluminium hydroxide and aspirin.[2][3]
Alternative Names and Combinations
Contraindications
- People with allergies to salicylates.
- People with gastrointestinal ulcers.
- People with liver or kidney damage.
- Pregnant women in the 3rd trimester.
- Women who are breastfeeding.
- Use with other salicylates.
- Use with NSAIDs.
External Links
References
- ↑ 1.0 1.1 MIMS. "Aloxiprin". MIMS. Retrieved 16 April 2011.
- ↑ Encarta. "Aloxiprin". Encarta. Retrieved 16 April 2011.
- ↑ CUMMINGS AJ, MARTIN BK, WIGGINS LF (1963). "In vitro and in vivo properties of aloxiprin: a new aluminium derivative of acetylsalicylic acid". J. Pharm. Pharmacol. 15: 56–62. PMID 14024235.
- ↑ Geller J (1968). "A comparative trial of aloxiprin ('Palaprin Forte') and phenylbutazone ('Butazolidin')". The British journal of clinical practice. 22 (9): 392–4. PMID 4876729.
- ↑ Net Doctor UK. "Askit Powders". Treatments for joint, muscle and bone conditions. Retrieved 16 April 2011.
- Pages with script errors
- CS1 maint: Multiple names: authors list
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drug
- Cardiovascular Drugs
- Antiplatelet drugs